Jennifer Gile

Willamette Valley Cancer Institute and Research Center

MedicineNursing

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Cabozantinib Following Immunotherapy in Patients with Advanced Hepatocellular Carcinoma”.

Cabozantinib Following Immunotherapy in Patients with Advanced Hepatocellular Carcinoma

Cancers(2022)10.3390/cancers14215173

N/A

0DataRank · unranked

16 citations

Jennifer Gile, Mathias Earl Palmer, Tyler Zemla, Daniel H. Ahn, Tanios Bekaii‐Saab +4 more

Outcomes following FGFR Inhibitor Therapy in Patients with Cholangiocarcinoma

Targeted Oncology(2022)10.1007/s11523-022-00914-w

N/A

0DataRank · unranked

8 citations

Vanessa Wookey, Tyler Zemla, Qian Shi, Zhaohui Jin, Steven R. Alberts +7 more

P-70 Outcomes following FGFR inhibitor therapy in patients with cholangiocarcinoma: Multi-center single institution cohort experience

Annals of Oncology(2022)10.1016/j.annonc.2022.04.160

N/A

0DataRank · unranked

0 citations

Vanessa Wookey, Tyler Zemla, Q. Shi, Tanios Bekaii‐Saab, Nguyen H. Tran +2 more

Evolving treatment patterns and improved outcomes in relapsed/refractory mantle cell lymphoma: a prospective cohort study

Blood Cancer Journal(2023)10.1038/s41408-023-00942-3

N/A

0DataRank · unranked

9 citations

Jennifer Gile, Melissa C. Larson, Kittika Poonsombudlert, Reema Tawfiq, Seth Maliske +14 more

Outcomes of Patients with Advanced Hepatocellular Carcinoma Receiving Lenvatinib following Immunotherapy: A Real World Evidence Study

Cancers(2023)10.3390/cancers15194867

N/A

0DataRank · unranked

8 citations

Jennifer Gile, Michael H. Storandt, Zhaohui Jin, Tyler Zemla, Nguyen H. Tran +2 more

Efficacy of first‐line checkpoint inhibitors in combination with chemotherapy in high‐grade extrapulmonary metastatic neuroendocrine carcinomas

Journal of Neuroendocrinology(2023)10.1111/jne.13283

N/A

0DataRank · unranked

1 citations

Patrick W. McGarrah, Konstantinos Leventakos, Mohamad Bassam Sonbol, Jason S. Starr, Rachel A. Eiring +3 more

Evaluation of prognostic scores in patients with HCC undergoing first-line immunotherapy with atezolizumab and bevacizumab

JHEP Reports(2024)10.1016/j.jhepr.2024.101295

N/A

0DataRank · unranked

9 citations

Philipp Mildenberger, Jennifer Gile, Fabian Jost‐Brinkmann, Bernhard Scheiner, Catherine Leyh +54 more

Hypomagnesemia in Large B cell Lymphoma patients receiving CAR T cell therapy correlates with immune dysregulation and decreased PFS: results from the ZUMA-1 trial and Mayo Clinic cohort

Research Square(2024)10.21203/rs.3.rs-4889200/v1

N/A

0DataRank · unranked

0 citations

Patrizia Mondello, Zixing Wang, Ying Li, Radhika Bansal, Sangeetha Gandhi +33 more

Hypomagnesemia in lymphoma patients receiving CAR T therapy correlates with immune dysfunction and decreased survival

Experimental Hematology and Oncology(2025)10.1186/s40164-025-00623-w

N/A

0DataRank · unranked

1 citations

Patrizia Mondello, Zixing Wang, Ying Li, Radhika Bansal, Sangeetha Gandhi +33 more